Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2024

Genmab — Januar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #50

    Nice one EL - but what the #%&& does study start “ 2026-03-09” mean? Study duration 120 weeks is a bit more digestable

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #51

      Trykfejl er mit gæt. Nok snarere 9. marts 24

      1 Reply Last reply
      0
      • K Offline
        K Offline
        kkjoel
        wrote on sidst redigeret af
        #52

        Ja, alene første sætning (ref Finans artiklen, 08:58): "Det danske biotekselskab Genmab specialiseret i moderne kræftbehandlinger kan være på vej ind i en ny fase med lav vækst efter år med utrolig vækst." Det er helt i hegnet i skoven at kalde en potentiel mindre vækst 7 år ude i fremtiden for "kan være på vej ind i". Enten forstår studentermedhjælperen ikke dansk. Eller osse manipulerer han bevidst. Jeg håber ikke Finans bifalder nogen af delene?!?

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #53

          Så er artiklen framet - Genmab i store problemer

          1 Reply Last reply
          0
          • J Offline
            J Offline
            JKY_VH
            wrote on sidst redigeret af
            #54

            Ja, sikke noget bavl

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #55

              that study start date seems odd indeed...

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #56

                Driving Disruption: Brad Bailey Of Genmab On The Innovative Approaches They Are Taking To Disrupt Their Industries https://medium.com/authority-magazine/driving-disruption-brad-bailey-of-genmab-on-the-innovative-approaches-they-are-taking-to-disrupt-08414da9c0b1

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  JKY_VH
                  wrote on sidst redigeret af
                  #57

                  “Blandt potentielle købere i 2024, ser vi Johnson & Johnson og Novo som mest tilbøjelige til at deltage i megahandler til en værdi af over 20 mia. dollar (136 mia. kr.), baseret på virksomhedernes opkøbsevne,” skriver Bank of America i en analyse af udviklingen på M&A for 2024. https://borsen.dk/nyheder/virksomheder/storbank-novo-nordisk-klar-til-megaopkob?b_source=borsen&b_medium=row_0&b_campaign=news_4

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    Klarussen
                    wrote on sidst redigeret af
                    #58

                    Godmorgen 🙂 @JKY: Tak for den. Det kan blive et meget spændende 2024 som Genmab aktionær.

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #59

                      Velbekomme, ja lad os håbe det;-)

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #60

                        Novartis interested in Interleukin-15 https://www.b3cnewswire.com/202401082504/calypso-enters-into-agreement-to-be-acquired-by-novartis.html -we can't be too far away from getting data on PRV-015 i would imagine, maybe towards the summer

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #61

                          JNJ buying another ADC biotech , Ambrx https://finance.yahoo.com/news/johnson-johnson-acquire-ambrx-advancing-123000192.html

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #62

                            Merck buying a small Tcell engager biotech, Harpoon Therapeutics https://finance.yahoo.com/news/merck-acquire-harpoon-therapeutics-further-123000116.html

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #63

                              Johnson & Johnson i milliardopkøb på kræftområdet https://www.proinvestor.com/investornyt/1100387/johnson-johnson-i-milliardopkob-pa-kraeftomradet

                              1 Reply Last reply
                              0
                              • royalR Offline
                                royalR Offline
                                royal
                                wrote on sidst redigeret af
                                #64

                                Herreste gud. Småpenge, men rigtig god præmie. 🙂

                                1 Reply Last reply
                                0
                                • royalR Offline
                                  royalR Offline
                                  royal
                                  wrote on sidst redigeret af
                                  #65

                                  Har JnJ 40 milliarder til at købe for?

                                  1 Reply Last reply
                                  0
                                  • nohopeN Offline
                                    nohopeN Offline
                                    nohope
                                    wrote on sidst redigeret af
                                    #66

                                    Hviken slags milliarder ?

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #67

                                      Er vi så klar med "Ja-hatten" royal?

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #68

                                        "New Year’s Update and Outlook for My Epcoritamab Trial" https://cllsociety.org/2024/01/new-years-update-and-outlook-for-my-epcoritamab-trial/

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #69

                                          "It’s early, but all seven CLL patients in the European study of epcoritamab who were in complete remission, like me, also achieved undetectable MRD with flow cytometry down to 1 in 10,000 cells."

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper